Evidence map›Paper›PMID 38981616›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2024

Secretagogue-induced pancreatitis in mice devoid of chymotrypsin.

Alexandra Demcsák, Siavash Shariatzadeh, Miklós Sahin-Tóth

Abstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Reevaluating the role of TRPV6 deficiency in human and mouse pancreatitis.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexandra DemcsákDepartment of Surgery, University of California Los Angeles, Los Angeles, California, United States.
Siavash ShariatzadehDepartment of Surgery, University of California Los Angeles, Los Angeles, California, United States.
Miklós Sahin-TóthDepartment of Surgery, University of California Los Angeles, Los Angeles, California, United States.ORCID 0000-0003-4513-9922

Funding

Chymotrypsin in pancreatitisR01DK082412 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SAHIN-TOTH, MIKLOS · 2009 to 2024
$5.8M
Trypsin-dependent mechanisms in pancreatitisR01DK117809 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SAHIN-TOTH, MIKLOS · 2018 to 2022
$2.5M
NIDDK NIH HHS R01 DK082412NIDDK NIH HHS R01 DK117809
6 · The paper itself

Abstract

The serine protease chymotrypsin protects the pancreas against pancreatitis by degrading trypsinogen, the precursor to the digestive protease trypsin. Taking advantage of previously generated mouse models with either the

Indexed as

CeruletideChymotrypsinMice, Inbred C57BLMice, KnockoutPancreatitisTrypsinAnimalsDisease Models, AnimalMaleMicePancreasSecretagoguesSerine EndopeptidasesCeruletideChymotrypsinchymotrypsin Bchymotrypsin CSecretagoguesSerine EndopeptidasesTrypsinacute pancreatitischronic pancreatitischymotrypsinchymotrypsinogentrypsintrypsinogen

Identifiers

PMID38981616
PMCPMC11427105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.